Venomyx Therapeutics

Early Stage

EpiPen for snakebites: the antivenom of tomorrow!

Analytics

Raised to Date: Raised: $297,421

Aggregate Commitments $

Platform

Wefunder

Start Date

03/14/2019

Close Date

07/03/2019

Min. Goal

$50,000

Max. Goal

$1,070,000

Min. Investment

$100

Security Type

SAFE

Funding Type

RegCF

Valuation Cap

$4,000,000

Discount Rate

15%

Rolling Commitments $

Status
Funded
Reporting Date

07/31/2019

Days Remaining
Funded
% of Min. Goal

595%

% of Max. Goal

28%

Likelihood of Max
Funded
Avg. Daily Raise

$2,679

# of Investors

506

Momentum
Funded
Create a free account today to gain access to KingsCrowd analytics.
Location

La Jolla, California

Industry

Healthcare & Pharmaceuticals

Tech Sector

Venomyx Therapeutics, with a valuation cap of $5 million, is raising crowdfunding on WeFunder. The company is developing Vipax, the world’s first broad-spectrum antivenom for snakebites. The product is ten times more effective than traditional antivenoms and much cheaper. Venomyx Therapeutics was founded by Daniel Dempsey and Deepankar Roy. The proceeds of the current crowdfunding round, with a minimum raise of $50,000, will be used to complete the preclinical trials, file an application to the FDA, and finish the research. Venomyx Therapeutics is expected to be a revolution while using biotechnology, and not animals, for the production of antivenom.
Create a free account today to gain access to KingsCrowd analytics.

Upgrade to gain access

Pay Monthly
Annually (Save 17%)

Edge

$12.42 /month
billed annually
Free portfolio tracking and KingsCrowd's quantitative ratings on all raises.
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings (excluding risk)
Advanced company search ( with ratings)
Markets page filters and historical industry data
Get Edge Annual

Edge Pro

$41.58 /month
billed annually
Full site access including KingsCrowd's qualitative analyst reports.
Plan Includes:
Everything in Edge, plus
Full access to detailed Analyst Reports (e.g. Top Deal, Deal to Watch, Neutral, and Underweight)
Search and filter based on Analyst Reports
In-depth risk ratings for every raise
Get Edge Pro Annual
Already a member? Log in here.

Create your first portfolio

Create your very own investment portfolio on KingsCrowd.

Now you can track all of your startup investments in one place utilizing our state-of-the-art portfolio tracker tools. To begin, create your first portfolio below.

Add to portfolio
Venomyx Therapeutics on Wefunder
$
Platform: Wefunder
Security Type: SAFE
Valuation: $4,000,000

Follow company

Follow Venomyx Therapeutics on Wefunder
View on Wefunder (Closed)
Bullish / Bearish
You're Bullish on Venomyx Therapeutics on Wefunder

Thank you for your vote on Venomyx Therapeutics on Wefunder

Bullish / Bearish
You're Bearish on Venomyx Therapeutics on Wefunder

Thank you for your vote on Venomyx Therapeutics on Wefunder